Update from Abano Healthcare

Apr 24, 2020 | Money Market

The Board and management of Abano Healthcare Group have progressed a detailed review of the business, given the impact of COVID-19. With the impact of COVID 19 on Abano’s revenue since mid-March, and the likely closure of practices into May 2020, Abano’s Underlying EBITDA for FY20 is now expected to be approximately $17m (pre-IFRS 16). […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options